Verona Pharma plc

Ownership Transactions Reported by 19 Insiders

Symbol
VRNA on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 More London Riverside, London, United Kingdom

Insiders trading volume in the past year

Verona Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Access Industries Holdings LLC 10%+ Owner $1.12B Aug 15, 2022
Rishi Gupta Director $75.6M May 11, 2023
Orbimed Advisors Llc Director $75.6M May 11, 2023
David Zaccardelli President and CEO, Director $71.1M -$10.8M -13.1% Dec 4, 2024
Mark Hahn Chief Financial Officer $66.6M -$10.8M -13.9% Dec 4, 2024
Claire Poll General Counsel $56M Feb 1, 2024
Kathleen A. Rickard Chief Medical Officer $13.1M -$1.25M -8.7% Nov 25, 2024
David R. Ebsworth Director $4.17M +$278K +7.13% Nov 18, 2024
Martin Edwards Director $2.9M Apr 29, 2024
Andrew Fisher General Counsel $1.31M Oct 30, 2024
Christina Ackermann Director $198K +$198K Nov 6, 2024
Anders Ullman Director Apr 29, 2024
Mahendra Shah Director Apr 29, 2024
Andrew Sinclair Director Aug 9, 2021
Kenneth Cunningham Director Apr 29, 2024
James Aloysius Brady Director Apr 29, 2024
Michael Austwick Director Feb 1, 2024
Vikas Sinha Director Apr 29, 2024
Lisa Deschamps Director Apr 29, 2024

Recent Insider Transactions by Companies or Individuals for Verona Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.